0000899243-21-011747.txt : 20210315
0000899243-21-011747.hdr.sgml : 20210315
20210315210810
ACCESSION NUMBER: 0000899243-21-011747
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20210311
FILED AS OF DATE: 20210315
DATE AS OF CHANGE: 20210315
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Jacobs Bruce N.
CENTRAL INDEX KEY: 0001821074
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-39460
FILM NUMBER: 21743354
MAIL ADDRESS:
STREET 1: C/O KYMERA THERAPEUTICS, INC.
STREET 2: 200 ARSENAL YARDS, SUITE 230
CITY: WATERTOWN
STATE: MA
ZIP: 02472
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Kymera Therapeutics, Inc.
CENTRAL INDEX KEY: 0001815442
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 812992166
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 300 TECHNOLOGY SQUARE
STREET 2: 2ND FLOOR
CITY: CAMBRIDGE
STATE: MA
ZIP: 02139
BUSINESS PHONE: 857-285-5314
MAIL ADDRESS:
STREET 1: 300 TECHNOLOGY SQUARE
STREET 2: 2ND FLOOR
CITY: CAMBRIDGE
STATE: MA
ZIP: 02139
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2021-03-11
0
0001815442
Kymera Therapeutics, Inc.
KYMR
0001821074
Jacobs Bruce N.
C/O KYMERA THERAPEUTICS, INC.
200 ARSENAL YARDS BLVD., SUITE 230
WATERTOWN
MA
02472
0
1
0
0
Chief Financial Officer
Common Stock
2021-03-11
4
M
0
1805
2.08
A
1805
D
Common Stock
2021-03-11
4
S
0
1805
60.0731
D
0
D
Common Stock
2021-03-15
4
M
0
8195
2.08
A
8195
D
Common Stock
2021-03-15
4
S
0
8195
60.1703
D
0
D
Stock Option (Right to Buy)
2.08
2021-03-11
4
M
0
1805
0.00
D
2030-08-19
Common Stock
1805
242256
D
Stock Option (Right to Buy)
2.08
2021-03-15
4
M
0
8195
0.00
D
2030-08-19
Common Stock
8195
234061
D
This sale was effected pursuant to a Rule 10b5-1 trading plan adopted on November 6, 2020.
The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $60.00 to $60.24. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.
The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $60.00 to $60.675. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.
Twenty-five percent (25%) of the shares underlying this stock option vested on July 1, 2020 and the remaining shares shall vest in equal monthly installments over the remaining thirty-six (36) months, subject to the reporting person's continued employment through each vesting date
/s/ Bruce N. Jacobs
2021-03-15